Peter M. Elias

Peter M. Elias

Direttore Tecnico/Scientifico/R&S presso Ceragenix Corp.

81 anni
3 relazioni
Consumer Services
Health Technology

Profilo

Peter M.
Elias is currently the Chief Scientific Officer at Ceragenix Corp.
He previously held the same position at OnSource Corp.
and Ceragenix Pharmaceuticals, Inc. Elias received his undergraduate degree from Stanford University and his graduate and doctorate degrees from The University of California, San Francisco.

Posizioni attive di Peter M. Elias

SocietàPosizioneInizio
Ceragenix Corp. Direttore Tecnico/Scientifico/R&S 01/05/2004
Tutte le posizioni attive di Peter M. Elias

Precedenti posizioni note di Peter M. Elias

SocietàPosizioneFine
OnSource Corp. Direttore Tecnico/Scientifico/R&S 27/06/2005
Ceragenix Pharmaceuticals, Inc.
Logo Ceragenix Pharmaceuticals, Inc.

Ceragenix Pharmaceuticals, Inc.

Pharmaceuticals: MajorHealth Technology

Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.

 Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di Peter M. Elias

Formazione di Peter M. Elias

Stanford University Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Peter M. Elias

Relazioni

3

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private3
OnSource Corp.

Consumer Services

Ceragenix Pharmaceuticals, Inc.
Logo Ceragenix Pharmaceuticals, Inc.

Ceragenix Pharmaceuticals, Inc.

Pharmaceuticals: MajorHealth Technology

Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.

Health Technology

Ceragenix Corp.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Peter M. Elias